Key facts
- This page summarizes Catherine A. Sohn's Form 4 filing for Maze Therapeutics, Inc. (MAZE).
- 10 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 08 Jan 2026, 16:30.
Catherine A. Sohn - 06 Jan 2026 Form 4 Insider Report for Maze Therapeutics, Inc. (MAZE)
- Reporting relationship
- Director
- Issuer ticker
- MAZE
- Reported as of
- 06 Jan 2026
- Net transaction value
- -$842,571
- SEC form
- 4
- Accepted by SEC
- 08 Jan 2026, 16:30:38 UTC
- Prior SEC filing
- 05 Jan 2026
- Next SEC filing
- 01 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Courtney Phillips, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Catherine A. Sohn filed Form 4 for Maze Therapeutics, Inc. (MAZE) on 08 Jan 2026.
Change
- Previous filing in this sequence was filed on 05 Jan 2026.
- Current net transaction value: -$842,571.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001555132
Primary reporting owner
Sohn Catherine A.
- Relationship
- Director
- Address
- C/O MAZE THERAPEUTICS, INC., 171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO
- Signature
- /s/ Courtney Phillips, as attorney-in-fact
- Signature date
- 08 Jan 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MAZE
transaction
Common Stock
Options Exercise
- Transaction value
- $25,977
- Shares
- +2,493
- Change %
- Price
- $10.42
- Shares after
- 2,493
- Date
- 06 Jan 2026
- Ownership
- Direct
MAZE
transaction
Common Stock
Sale
- Transaction value
- $96,270
- Shares
- -2,493
- Change %
- -100%
- Price
- $38.62
- Shares after
- 0
- Date
- 06 Jan 2026
- Ownership
- Direct
- Footnotes
- F1
MAZE
transaction
Common Stock
Options Exercise
- Transaction value
- $216,152
- Shares
- +20,744
- Change %
- Price
- $10.42
- Shares after
- 20,744
- Date
- 07 Jan 2026
- Ownership
- Direct
MAZE
transaction
Common Stock
Options Exercise
- Transaction value
- $30,166
- Shares
- +2,895
- Change %
- +14%
- Price
- $10.42
- Shares after
- 23,639
- Date
- 07 Jan 2026
- Ownership
- Direct
MAZE
transaction
Common Stock
Options Exercise
- Transaction value
- $34,188
- Shares
- +3,281
- Change %
- +14%
- Price
- $10.42
- Shares after
- 26,920
- Date
- 07 Jan 2026
- Ownership
- Direct
MAZE
transaction
Common Stock
Sale
- Transaction value
- $1,052,785
- Shares
- -26,920
- Change %
- -100%
- Price
- $39.11
- Shares after
- 0
- Date
- 07 Jan 2026
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MAZE
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,493
- Change %
- -44%
- Price
- $0.000000
- Shares after
- 3,211
- Date
- 06 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,493
- Exercise price
- $10.42
- Footnotes
- F3
MAZE
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -20,744
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 07 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,744
- Exercise price
- $10.42
- Footnotes
- F4
MAZE
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,895
- Change %
- -90%
- Price
- $0.000000
- Shares after
- 316
- Date
- 07 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,895
- Exercise price
- $10.42
- Footnotes
- F3
MAZE
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -3,281
- Change %
- -36%
- Price
- $0.000000
- Shares after
- 5,805
- Date
- 07 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,281
- Exercise price
- $10.42
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.61 to $38.6225 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 2 of this Form 4.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.04 to $39.85 per share, inclusive.
Footnote F3
The option vested or vests as to 1/36th of the total award monthly, with the first tranche vested on April 1, 2023, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
Footnote F4
The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on February 2, 2024.
Footnote F5
The option vested or vests as to 1/36th of the total award monthly, with the first tranche vested on January 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.